@drdradamlin.bsky.social
HSCT&Cell Therapy Physician | Nanotechnology and Biomaterials Lab for Blood Cancers | Lymphoma | Physician Scientist | Assistant Professor @NU & RHLCCC
No Kings Day
15.06.2025 00:54 — 👍 0 🔁 0 💬 0 📌 0Dr. Éliane Gluckman revolutionized #hematology by performing the 1st human cord blood transplant. Since then, there have been more than 40K transplants, with cord blood registries established worldwide. 🩸✨
Watch this video about her amazing career https://bit.ly/3DnxswP
#ASH24 #Hemesky
Follow us all now #platelets #coagulation 🧪
#hemesky #cardiosky #Thrombosky
Orca-Q Leads to Low Rates of GVHD, Non-Relapse Mortality in High-Risk Hematologic Malignancies After Allo-HCT @ash-hematology.bsky.social #ASH24 #hematology #oncology www.onclive.com/view/orca-q-...
16.12.2024 20:31 — 👍 1 🔁 1 💬 0 📌 0
🌡️ Fever of Unknown Origin (FUO) = temp >38.3C multiple times x 3 weeks without obvious cause
Infections: 20-40%.
Connective tissue disorders: 20%
Malignancy: 10-20%
Undiagnosed: 20%
Drugs (e.g., phenytoin): rare
#medsky #IMsky #internalmedicine #IDsky #hemeonc #hemesky #oncsky #rheumsky
Out in @bloodjournal during #ASH24 - cool work by @freemanlciaraMD @DrFredLocke et al looking at #MMsm CAR-T in myeloma:
MTV (by PET-CT), sBCMA, BMPC don't always correlate. Some MTV-high but sBCMA-low pts exist - may not respond durably to BCMA CAR-T.
ashpublications.org/blood/articl...
Slide on financial toxicity of cancer care
Staggering statistics at #ASH24 #TreatingFairly
Patients with cancer who go bankrupt are nearly 80% more likely to die regardless of disease status.
Our system quite literally kills people.
Megan Melody presenting important data on bi specific antibodies after CAR T progression at ASH24
08.12.2024 19:01 — 👍 4 🔁 1 💬 0 📌 1
Wisdom doesn’t come from experience. It comes from reflecting on experience.
Between ages 25 and 75, the correlation between age and wisdom is zero.
Gaining insight and perspective is not about the number of years you've lived. It's about the number of lessons you've learned.
Scientists have made major strides in engineering CAR-T cell therapies to treat autoimmune disorders such as lupus, according to a new #ScienceTranslationalMedicine Review that discusses the latest breakthroughs and clinical trials in the field. scim.ag/4f0RmL1
04.12.2024 18:30 — 👍 41 🔁 7 💬 0 📌 1
The possible “catastrophic success” of CAR-T cells in cancer and autoimmune disease @science.org. A nice story on dramatic diseases, biomedical technology and sustainability.. bit.ly/4i9FXf1 #oncosky #medsky #oncsky 🧪
25.11.2024 05:36 — 👍 652 🔁 68 💬 4 📌 4
MRD-adapted 1L ven+obin CLL #ASH24:
- MRD stopping criteria below
- 100 pts, 16% TP53mut
- 2-yr PFS/OS 92%/95%
- 41 pts uMRD6 at C7, 3 pts req'd all 24 cycles
Great to stop VO even earlier for pts w/ early uMRD. #lymsm
Such a thoughtful way to share thanks!
27.11.2024 00:11 — 👍 9 🔁 4 💬 1 📌 0
